BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29941389)

  • 1. Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication Rates.
    Salomon G; Prues S; Saul J; Budäus L; Tilki D; Schneider M; Haferkamp A; Graefen M; Boehm K
    Eur Urol Focus; 2019 Nov; 5(6):992-997. PubMed ID: 29941389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications After Systematic, Random, and Image-guided Prostate Biopsy.
    Borghesi M; Ahmed H; Nam R; Schaeffer E; Schiavina R; Taneja S; Weidner W; Loeb S
    Eur Urol; 2017 Mar; 71(3):353-365. PubMed ID: 27543165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy: results from a prospective randomized trial.
    Salomon G; Saul J; Prues S; Schneider M; Budäus L; Tilki D; Rohde H; Haferkamp A; Graefen M; Boehm K
    World J Urol; 2018 Jun; 36(6):871-876. PubMed ID: 29417288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.
    Knaapila J; Gunell M; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Hakanen AJ; Boström PJ
    Eur Urol Focus; 2019 May; 5(3):443-448. PubMed ID: 29275146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Previous Prostate Biopsy Related Complications and the Type of Complication with Patient Compliance with Rebiopsy Scheme.
    Schwarzman LS; Abern MR; Garvey DF; Andriole GL; Freedland SJ; Moreira DM
    J Urol; 2018 Nov; 200(5):1062-1067. PubMed ID: 29906435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
    Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial.
    Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
    Urology; 2007 Sep; 70(3):501-5. PubMed ID: 17688919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
    Lee JK; Lee S; Hong SK; Byun SS; Lee SE
    BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Two Fosfomycin Regimens as Antimicrobial Prophylaxis for Transrectal Prostate Biopsy: A Randomised Study.
    D'Elia C; Mian C; Hanspeter E; Ladurner C; Palermo SM; Pycha S; Saleh O; Cai T; Spoladore G; Kafka M; Pycha A; Trenti E
    Urol Int; 2019; 103(4):433-438. PubMed ID: 31614361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy.
    Chambó RC; Tsuji FH; Yamamoto HA; Jesus CM
    Int Braz J Urol; 2015; 41(1):46-56. PubMed ID: 25928510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Experience of Systematic Versus Fusion Prostate Biopsies.
    Eineluoto JT; Järvinen P; Kilpeläinen T; Lahdensuo K; Kalalahti I; Sandeman K; Mirtti T; Rannikko A
    Eur Urol Oncol; 2018 Aug; 1(3):202-207. PubMed ID: 31102622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy.
    Wenzel M; Welte MN; Theissen LH; Wittler C; Hoeh B; Humke C; Preisser F; Würnschimmel C; Tilki D; Graefen M; Roos FC; Becker A; Karakiewicz PI; Chun FKH; Kluth LA; Mandel P
    Eur Urol Focus; 2021 Sep; 7(5):980-986. PubMed ID: 33358884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
    Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
    Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Different Rectal Cleansing Methods for Reducing Post-Procedural Infectious Complications After Transrectal Ultrasound-Guided Prostate Biopsy.
    Lee JE; Shin SS; Kang TW; Kim JW; Heo SH; Jeong YY
    Urol J; 2020 Jan; 17(1):36-41. PubMed ID: 30882162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer.
    Ganeswaran D; Sweeney C; Yousif F; Lang S; Goodman C; Nabi G
    World J Urol; 2014 Apr; 32(2):309-15. PubMed ID: 22736233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing infective complications from transrectal ultrasound guided prostate biopsy following transition to single dose oral ciprofloxacin prophylaxis.
    Farag M; Riddell S; Daffy J; Wong LM
    Investig Clin Urol; 2019 Jan; 60(1):54-60. PubMed ID: 30637362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.